ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Astragalus polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCC

He, Lihua; Xu, Kecheng; Niu, Lizhi; Lin, Lizhu*广州中医药大学; 1
PHARMACEUTICAL BIOLOGY2022-12-31DOI: 10.1080/13880209.2022.2112963
5被引10阅读
引用收藏
分享

摘要

Context Astragalus polysaccharide (APS) is a new tumour therapeutic drug, that has an inhibitory effect on a variety of solid tumours. Tumour cell immunosuppression is related to the up-regulation of programmed death ligand 1 (PD-L1). However, whether APS exerts its antitumor effect by regulating PD-L1 remains unclear. Objective To explore whether APS exerts its antineoplastic effect via regulating PD-L1-mediated immunosuppression in hepatocellular carcinoma (HCC). Materials and methods SMMC-7721 cells were subcutaneous injected into BALB/C mice for HCC model establishment. Mice were intraperitoneally injected with 100, 200 and 400 mg/kg APS for 12 days. Immunohistochemistry (IHC) was performed to assess CD8(+) T cells' rate and PD-L1 level in HCC tissues. HCC cells were pre-treated with 0.1, 0.5 and 1 mg/mL APS for 4 h, then were treated with 10 ng/mL IFN-gamma 24 h. PD-L1 level and cell apoptosis was detected by flow cytometry. PD-L1 and Moesin (MSN) proteins were measured by western blot. MiR-133a-3p and MSN mRNA levels were assessed by qRT-PCR. The targets of miR-133a-3p were predicted by starBase, and which was verified by dual-luciferase reporter assay. Results Our findings illustrated that APS dose-dependently inhibited HCC growth tested with IC50 values of 4.2 mg/mL, and IFN-gamma-induced PD-L1 expression and attenuated PD-L1-mediated immunosuppression in HCC cells. APS attenuated PD-L1-mediated immunosuppression via miR-133a-3p in HCC cells. Besides, miR-133a-3p targeted to MSN, and MSN inhibited the antitumor effect of APS by maintaining the stability of PD-L1. Moreover, APS attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis. Conclusions APS attenuated PD-L1-mediated immunosuppression via miR-133a-3p/MSN axis to develop an antitumor effect. APS may be an effective drug for HCC treatment.

学科与关键词

关键词
Hepatocellular carcinomaAstragalus polysaccharidemoesin
相关
加载中…
  • microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3
    Li, Yaqin; Zhou, Tao; Cheng, Xianyi; Li, Dezhi; Zhao, Meng; Zheng, Wei, V*Bioengineered, 2022, 13(3): 4730-4743.被引 14
  • Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo
    Sha, Xinrui; Xu, Xia; Liao, Shuangye; Chen, Hongyuan*; Rui, Wen*Experimental Cell Research, 2022, 410(1): 112948.被引 7
  • Recent advances in natural polysaccharides against hepatocellular carcinoma: A review
    Wang, Dazhen; Zhang, Zhengfeng; Zhao, Lu; Yang, Liu; Lou, ChangJie*International Journal of Biological Macromolecules, 2023, 253: 126766.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHARMACEUTICAL BIOLOGY
发表日期
2022-12-31
卷期
第 60 卷, 第 1 期
页码
1710-1720
DOI
10.1080/13880209.2022.2112963
语言
ENGLISH
期刊等级
3区
成果收录
SCIE

作者

  • H

    He, Lihua (第一作者)

    guangzhou univ tradit chinese med

  • X

    Xu, Kecheng

查看全部 4 位作者收起作者
  • N

    Niu, Lizhi

  • L

    Lin, Lizhu (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417